Fig. 2.
Manhattan and QQ plots of SNP-based and Gene-Based genome-wide association results of neuropathological features of AD (n = 6960). Dotted red lines represent the threshold for genome-wide significance (P < 5 × 10−8) and Bonferroni correction for the gene-based analyses. A Neuropathologically-confirmed AD case–control GWAS. B Gene-based analysis for neuropathologically confirmed AD case–control sample. C Braak stage GWAS. D Gene-based analysis for Braak stage. E NP score GWAS. F Gene-based analysis for NP score
